Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.
about
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.Atrial fibrillation and quality of life related to disease and treatment: focus on anticoagulation.Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Edoxaban in the prevention and treatment of thromboembolic complications from a clinical point of view.Clinical development of rivaroxaban: emerging new clinical evidences?Use of direct oral anticoagulants in patients with nonvalvular atrial fibrillation according to clinical profile.Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practice.Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice.Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery.Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.Prevalence of renal dysfunction according to the type of atrial fibrillation and anticoagulation treatment in patients who attended primary care in Spain.Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.Decision Algorithms for Direct Oral Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: A Practical Guide for Neurologists.
P2860
Q33427274-C0ABB448-B3AA-4B24-A3D2-CEA8322204E5Q38221812-524478FF-9B7D-4926-BAC9-37FF6007581AQ38224401-74A6AF64-938F-4EB8-B79D-3AB6DE4D1F33Q38287849-39597D1F-DE3E-41F0-8198-D4AD84A03991Q38386998-5267DAC3-C864-4418-9415-7C4C1331511DQ38525918-4588EEE6-ED84-4FA2-9E89-B99A0322D81BQ38537785-0FC61317-FA0C-447A-8E4B-4E87D30EB4E6Q38812464-64725545-EE9C-4ED0-9A35-F5BF3DE0D4D1Q38819152-B9A56C25-7A4C-4A53-940D-FD0E0E5FD3A6Q38953655-11B5DEC9-330D-4AFF-87BF-332D90951C32Q38993962-A9FC9FA1-C191-4870-B381-3FAE4E46DCE7Q39031152-41483582-D681-414F-AAE7-B45BE5CE00E7Q39187952-41CEE761-0CC7-486E-901D-F72C8E881590Q39204242-21B26C98-A0DF-48C1-88CE-BBF882FF5601Q41341319-28032316-852D-4942-AB85-332315E50ACCQ47686273-7EF95301-3A07-4CDA-83A6-A1262C0866F4
P2860
Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rivaroxaban: a once-daily anti ...... thromboembolic complications.
@en
type
label
Rivaroxaban: a once-daily anti ...... thromboembolic complications.
@en
prefLabel
Rivaroxaban: a once-daily anti ...... thromboembolic complications.
@en
P2860
P356
P1476
Rivaroxaban: a once-daily anti ...... thromboembolic complications.
@en
P2093
Carlos Escobar
Vivencio Barrios
P2860
P304
P356
10.1586/ERC.12.172
P577
2013-02-01T00:00:00Z